Pathologists Aim For Better Communication Following Faulty Lab Test Results
This article was originally published in The Gray Sheet
Executive Summary
CMS will convene a meeting of medical facility accreditation organizations and government oversight bodies to address the need for improved communication between inspectors, according to College of American Pathologists President Mary Kass
You may also be interested in...
Maryland Hospital False Test Results Prompt Hill Inquiry; FDA, CMS Respond
FDA plans to inspect Adaltis, Inc.'s Italian manufacturing facilities in "late June or early July," following a Congressional hearing May 18 related to reports of faulty test results from the firm's Labotech analyzer at a Maryland hospital
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.